B-blockers treatment of cardiac surgery patients enhances isolation and improves phenotype of cardiosphere-derived cells

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Chimenti, Isotta ^a   Pagano, Francesca ^a   Cavarretta, Elena ^a   Angelini, Francesco ^a   Peruzzi, Mariangela ^a   Barretta, Antonio ^b   Greco, Ernesto ^b   De Falco, Elena ^a   Marullo, Antonino G M ^a   Sciarretta, Sebastiano ^a,c   Biondi Zoccai, Giuseppe ^a,c   Frati, Giacomo ^a,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

^c IRCCS NEUROMED   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; MICRORNA;

AGED; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CELL CULTURE; CELL PROLIFERATION; CELL SEPARATION; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENETICS; HEART DISEASE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MULTICELLULAR SPHEROID; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; STEM CELL;

ADRENERGIC BETA-ANTAGONISTS; AGED; CELL PROLIFERATION; CELL SEPARATION; CELLS, CULTURED; FEMALE; GENE EXPRESSION; HEART DISEASES; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MYOCARDIUM; MYOCYTES, CARDIAC; PHENOTYPE; SPHEROIDS, CELLULAR; STEM CELLS;

EID: 84995503421     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep36774     Document Type: Article

References (67)

1. Kass, D. A. et al. Reverse remodeling from cardiomyoplasty in human heart failure. External constraint versus active assist. Circulation 91, 2314-2318 (1995).
2. Chatterjee, S. et al. Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis. BMJ 346, f55 (2013).
3. Koitabashi, N. & Kass, D. A. Reverse remodeling in heart failure-mechanisms and therapeutic opportunities. Nat Rev Cardiol 9, 147-157 (2012).
4. Lowes, B. D. et al. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. N Engl J Med 346, 1357-1365 (2002).
5. Hou, Y. et al. Beta-adrenoceptor regulates miRNA expression in rat heart. Med Sci Monit 18, BR309-BR314 (2012).
6. Zhu, W. et al. MicroRNA expression analysis: clinical advantage of propranolol reveals key microRNAs in myocardial infarction. PLoS One 6, e14736 (2011).
7. Castaldi, A. et al. MicroRNA-133 modulates the β 1-adrenergic receptor transduction cascade. Circ Res 115, 273-283 (2014).
8. Wang, W. C., Juan, A. H., Panebra, A. & Liggett, S. B. MicroRNA let-7 establishes expression of beta2-adrenergic receptors and dynamically down-regulates agonist-promoted down-regulation. Proc Natl Acad Sci USA 108, 6246-6251 (2011).
9. Rosen, M. R., Myerburg, R. J., Francis, D. P., Cole, G. D. & Marbán, E. Translating stem cell research to cardiac disease therapies: pitfalls and prospects for improvement. J Am Coll Cardiol 64, 922-937 (2014).
10. Forte, E. et al. Cardiac cell therapy: the next (re)generation. Stem Cell Rev 7, 1018-1030 (2011).
11. Chimenti, I., Forte, E., Angelini, F., Messina, E. & Giacomello, A. Biochemistry and biology: heart-to-heart to investigate cardiac progenitor cells. Biochim Biophys Acta 1830, 2459-2469 (2013).
12. Peruzzi, M. et al. State of the Art on the Evidence Base in Cardiac Regenerative Therapy: Overview of 41 Systematic Reviews. Biomed Res Int 2015, 613782 (2015).
13. Gaetani, R. et al. Different types of cultured human adult cardiac progenitor cells have a high degree of transcriptome similarity. J Cell Mol Med 18, 2147-2151 (2014).
14. Li, T. S. et al. Cardiospheres recapitulate a niche-like microenvironment rich in stemness and cell-matrix interactions, rationalizing their enhanced functional potency for myocardial repair. Stem Cells 28, 2088-2098 (2010).
15. Messina, E. et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 95, 911-921 (2004).
16. Forte, E. et al. TGFbeta-dependent epithelial-to-mesenchymal transition is required to generate cardiospheres from human adult heart biopsies. Stem Cells Dev 21, 3081-3090 (2012).
17. Chimenti, I., Forte, E., Angelini, F., Giacomello, A. & Messina, E. From Ontogenesis to Regeneration: Learning how to Instruct Adult Cardiac Progenitor Cells. Prog Mol Biol Transl Sci 111, 109-137 (2012).
18. Siciliano, C. et al. Cardiosphere conditioned media influence the plasticity of human mediastinal adipose tissue-derived mesenchymal stem cells. Cell transplantation 24, 2307-2322 (2015).
19. Lee, S. T. et al. Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction. J Am Coll Cardiol 57, 455-465 (2011).
20. Makkar, R. R. et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 379, 895-904 (2012).
21. Chimenti, I. et al. Serum and supplement optimization for EU GMP-compliance in cardiospheres cell culture. J Cell Mol Med 18, 624-634 (2014).
22. Ellison, G. M. et al. Adult c-kit (pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. Cell 154, 827-842 (2013).
23. Friedl, G., Windhager, R., Schmidt, H. & Aigner, R. The osteogenic response of undifferentiated human mesenchymal stem cells (hMSCs) to mechanical strain is inversely related to body mass index of the donor. Acta Orthop 80, 491-498 (2009).
24. King, T. F. & McDermott, J. H. Endothelial progenitor cells and cardiovascular disease. J Stem Cells 9, 93-106 (2014).
25. Gambini, E. et al. Patient profile modulates cardiac c-kit (+) progenitor cell availability and amplification potential. Transl Res 160, 363-373 (2012).
26. Sung, S. H. et al. Reduced number and impaired function of circulating endothelial progenitor cells in patients with abdominal aortic aneurysm. Int J Cardiol 168, 1070-1077 (2013).
27. Li, T. S. et al. Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J Am Coll Cardiol 59, 942-953 (2012).
28. Cheng, K. et al. Relative roles of CD90 and c-kit to the regenerative efficacy of cardiosphere-derived cells in humans and in a mouse model of myocardial infarction. J Am Heart Assoc 3, e001260 (2014).
29. Shen, D., Cheng, K. & Marbán, E. Dose-dependent functional benefit of human cardiosphere transplantation in mice with acute myocardial infarction. J Cell Mol Med 16, 2112-2116 (2012).
30. Khan, M. et al. β -Adrenergic regulation of cardiac progenitor cell death versus survival and proliferation. Circ Res 112, 476-486 (2013).
31. Urbanek, K. et al. Stem cell niches in the adult mouse heart. Proc Natl Acad Sci USA 103, 9226-9231 (2006).
32. Birks, E. J. Molecular changes after left ventricular assist device support for heart failure. Circ Res 113, 777-791 (2013).
33. Gago-Lopez, N. et al. THY-1 receptor expression differentiates cardiosphere-derived cells with divergent cardiogenic differentiation potential. Stem Cell Reports 2, 576-591 (2014).
34. Smith, R. R., Chimenti, I. & Marban, E. In AHA Scientific Session. (ed Circulation) S-420 (Circulation) (2008).
35. Thum, T. et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456, 980-984 (2008).
36. Cavarretta, E. & Condorelli, G. miR-21 and cardiac fibrosis: another brick in the wall? Eur Heart J 36, 2139-2141 (2015).
37. Pan, Z. et al. MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-beta1 pathway. Circulation 126, 840-850 (2012).
38. van Rooij, E. et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 105, 13027-13032 (2008).
39. Cavarretta, E., Latronico, M. V. & Condorelli, G. Endothelial-to-mesenchymal transition and microRNA-21: the game is on again. Arterioscler Thromb Vasc Biol 32, 165-166 (2012).
40. Ivey, K. N. et al. MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell 2, 219-229 (2008).
41. Muraoka, N. et al. MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures. EMBO J 33, 1565-1581 (2014).
42. Sluijter, J. P. et al. MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. Arterioscler Thromb Vasc Biol 30, 859-868 (2010).
43. Izarra, A. et al. miR-133a enhances the protective capacity of cardiac progenitors cells after myocardial infarction. Stem Cell Reports 3, 1029-1042 (2014).
44. Siemens, H. et al. miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions. Cell Cycle 10, 4256-4271 (2011).
45. Barile, L. et al. Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovasc Res 103, 530-541 (2014).
46. Ibrahim, A. G., Cheng, K. & Marban, E. Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Reports 2, 606-619 (2014).
47. Lu, Y. et al. MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection. Cardiovasc Res 84, 434-441 (2009).
48. Xu, C. et al. β -Blocker carvedilol protects cardiomyocytes against oxidative stress-induced apoptosis by up-regulating miR-133 expression. J Mol Cell Cardiol 75, 111-121 (2014).
49. Latham, N. et al. Human blood and cardiac stem cells synergize to enhance cardiac repair when cotransplanted into ischemic myocardium. Circulation 128, S105-S112 (2013).
50. Ye, H. et al. Nebivolol induces distinct changes in profibrosis microRNA expression compared with atenolol, in salt-sensitive hypertensive rats. Hypertension 61, 1008-1013 (2013).
51. Smith, R. R. et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115, 896-908 (2007).
52. van Berlo, J. H. et al. c-kit + cells minimally contribute cardiomyocytes to the heart. Nature 509, 337-341 (2014).
53. Turner, N. A. et al. Chronic beta2-adrenergic receptor stimulation increases proliferation of human cardiac fibroblasts via an autocrine mechanism. Cardiovasc Res 57, 784-792 (2003).
54. Jugdutt, B. I. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation 108, 1395-1403 (2003).
55. D'Amario, D. et al. Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery. Circulation 129, 157-172 (2014).
56. Condorelli, G., Latronico, M. V. & Cavarretta, E. microRNAs in cardiovascular diseases: current knowledge and the road ahead. J Am Coll Cardiol 63, 2177-2187 (2014).
57. Fuentes, T. I. et al. Human neonatal cardiovascular progenitors: unlocking the secret to regenerative ability. PLoS One 8, e77464 (2013).
58. Eulalio, A. et al. Functional screening identifies miRNAs inducing cardiac regeneration. Nature 492, 376-381 (2012).
59. Lu, T. Y. et al. Overexpression of microRNA-1 promotes cardiomyocyte commitment from human cardiovascular progenitors via suppressing WNT and FGF signaling pathways. J Mol Cell Cardiol 63, 146-154 (2013).
60. Duisters, R. F. et al. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res 104, 170-178, 176p following 178 (2009).
61. Hassan, F. et al. Carvedilol enhances mesenchymal stem cell therapy for myocardial infarction via inhibition of caspase-3 expression. J Pharmacol Exp Ther 343, 62-71 (2012).
62. Shin, S. Y. et al. The switching role of β -adrenergic receptor signalling in cell survival or death decision of cardiomyocytes. Nat Commun 5, 5777 (2014).
63. Rehsia, N. S. & Dhalla, N. S. Mechanisms of the beneficial effects of beta-adrenoceptor antagonists in congestive heart failure. Exp Clin Cardiol 15, e86-e95 (2010).
64. Lotrionte, M. et al. Temporal changes in standard and tissue Doppler imaging echocardiographic parameters after anthracycline chemotherapy in women with breast cancer. Am J Cardiol 112, 1005-1012 (2013).
65. Lang, R. M. et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18, 1440-1463 (2005).
66. Chimenti, I. et al. Isolation and expansion of adult cardiac stem/progenitor cells in the form of cardiospheres from human cardiac biopsies and murine hearts. Methods Mol Biol 879, 327-338 (2012).
67. Andersen, C. L., Jensen, J. L. & Ørntoft, T. F. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64, 5245-5250 (2004).